DK162419B - ORAL COSMETICS THAT EFFECTS THE TURTLE - Google Patents
ORAL COSMETICS THAT EFFECTS THE TURTLE Download PDFInfo
- Publication number
- DK162419B DK162419B DK480582A DK480582A DK162419B DK 162419 B DK162419 B DK 162419B DK 480582 A DK480582 A DK 480582A DK 480582 A DK480582 A DK 480582A DK 162419 B DK162419 B DK 162419B
- Authority
- DK
- Denmark
- Prior art keywords
- approx
- tartar
- agent
- agents
- bis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Description
DK 162419 BDK 162419 B
Opfindelsen angår mundplejemidler indeholdende et antitand-stensmiddel.The invention relates to oral care agents containing an anti-tooth stone agent.
Tandsten er en hård mi neraliseret dannelse, som danner sig på 5 tænderne. Regelmæssig børstning forhindrer en hurtig opbygning af disse aflejringer, men selv regelmæssig børstning er ikke tilstrækkelig til at fjerne al tandstenen, som er aflejret, og som hænger fast ved tænderne. Tandsten dannes på tænderne, når krystaller af calciumphosphat begynder at blive aflejret i 10 hinden og den ekstracellulære grundmasse af dentalplak bliver tilstrækkeligt tæt sammenpakket til, at aggregaterne bliver modstandsdygtige mod deformation. Der er ikke fuldstændig enighed om den vej, ad hvilken calcium og orthophosphat til slut bliver det krystallinske materiale, der kaldes hydroxy-15 apatit (HAP). Der er imidlertid almindelig enighed om, at ved højere mætninger, dvs. over den kritiske mætningsgrænse, er forstadiet til krystallinsk hydroxyapatit et amorft eller mi-krokrystal1 i nsk calciumphosphat. "Amorft calciumphosphat" er ganske vist beslægtet med hydroxyapatit, men adskiller sig 20 derfra i sin atomare struktur, partikelmorfologi og støkiometri. Røntgendiffraktionsmønstre af amorft calciumphosphat viser brede toppe, der er typiske for amorfe materialer, som mangler den langtrækkende atomare orden, som er karakteristisk for alle krystallinske materialer, herunder hydroxyapatit. En 25 foreslået mekanisme, ved hvilken de ugiftige antitandstensmid-ler ifølge opfindelsen hæmmer tandstensdannelse, indebærer sandsynligvis, at disse midler virker til at binde aminogrup-per i grundmassesystemet i mundhulen ved en fysiologisk pH-værdi og fysiologiske temperaturer og også tværbinder protei-30 net.Tartar is a hard mineralized formation that forms on the 5 teeth. Regular brushing prevents rapid build-up of these deposits, but even regular brushing is not enough to remove all the tartar that is deposited and which sticks to the teeth. Tartar is formed on the teeth as calcium phosphate crystals begin to deposit in the retina and the extracellular matrix of dental plaque becomes tightly packed enough to make the aggregates resistant to deformation. There is no complete consensus on the path by which calcium and orthophosphate eventually become the crystalline material called hydroxy-apatite (HAP). However, there is a general consensus that at higher saturations, i.e. Above the critical saturation limit, the precursor to crystalline hydroxyapatite is an amorphous or microcrystalline calcium phosphate. "Amorphous calcium phosphate" is similar to hydroxyapatite, but differs therefrom in its atomic structure, particle morphology and stoichiometry. X-ray diffraction patterns of amorphous calcium phosphate show broad peaks typical of amorphous materials lacking the long-range atomic order characteristic of all crystalline materials, including hydroxyapatite. A proposed mechanism by which the non-toxic anti-tartar agents of the invention inhibit tartar formation probably implies that these agents act to bind amino groups in the oral cavity system at a physiological pH and physiological temperatures and also cross-link the protein. .
Et betydeligt antal forskellige typer forbindelser og midler er blevet udviklet til brug som antibakterielle midler, anti-plak-midler og antitandstensmidler i mundplejemidler, herunder 35 f.eks. sådanne kationiske materialer som bis-biguanid-forbin delserne og kvaternære ammoniumforbindelser, f.eks. benzetho-niumchlorid og cetylpyridiniumchlorid. Disse kationiske mateA considerable number of different types of compounds and agents have been developed for use as antibacterial agents, anti-plaque agents, and anti-dentifrice agents in oral care products, including e.g. such cationic materials as the bis-biguanide compounds and quaternary ammonium compounds, e.g. benzethonium chloride and cetylpyridinium chloride. These cationic mates
DK 162419 BDK 162419 B
2 rialer er dog tilbøjelige til at misfarve tænderne ved fortsat brug.However, 2 rials are prone to discoloring the teeth when continued use.
Ifølge US patentskrift nr. 4.080.441 foreslås det at inhibere 5 den ovennævnte misfarvning, som forårsages af de kationiske antibakterielle antiplakmidler ved, at man til mundpiejemidlet som et antimisfarvningsadditiv tilsætter en forbindelse, for hvilken det nu har vist sig som beskrevet nærmere i det følgende, at den i sig selv virker som et effektivt oralt anti-10 tandstensmiddel i fravær af de kationiske antibakterielle an tiplakmidler.According to U.S. Patent No. 4,080,441, it is proposed to inhibit the above discoloration caused by the cationic antibacterial anti-stick agents by adding to the mouthpiece as an anti-stain additive a compound for which it has now been found to be more fully described hereinafter. in itself acts as an effective oral anti-tartaric agent in the absence of the cationic antibacterial anti-lacquer agents.
Formålet med opfindelsen er at angive et forbedret mundpleje-middel, der modvirker tandsten, som har forholdsvis lille el-15 ler ingen tendens til at misfarve tænderne.The object of the invention is to provide an improved oral care agent which counteracts tartar which has relatively small or no tendency to discolor teeth.
Opfindelsen angår et i hovedsagen vandfrit mundplejemiddel, der er uden misfarvningsfremkaldende antibakterielle antiplakmidler, og som omfatter en oralt acceptabel bærer, og i ert ef-20 fektiv mængde som anti tandstensmiddel mindst én bis(o-carbo- xyphenyl)ester af en C2-C8 alifatisk dicarboxylsyre.BACKGROUND OF THE INVENTION This invention relates to a substantially anhydrous oral care agent which is free of discolouring antibacterial antibacterial agents and comprises an orally acceptable carrier, and in an effective amount as anti-tartaric agent, at least one bis (o-carboxyphenyl) ester of a C2-C8. aliphatic dicarboxylic acid.
Antitandstensmidlerne ifølge opfindelsen kan repræsenteres i deres frie syreform ved formlen 25The anti-tartar agents of the invention may be represented in their free acid form by formula 25
OOC -(CRRl. - COOOOC - (CRR1 - COO
1 n λ1 n λ
-COOH HOOC-COOH HOOC
30 hvori fortrinsvis R'erne uafhængigt af hinanden er H eller C1-4 alkyl, fortrinsvis H, og n er et tal fra 0-6, fortrinsvis 2, idet det foretrukne antitandstensmiddel er bis-(o-carboxy-35 phenyl) succinat (BOCS). Gruppen -(CRR)n- kan dog være en en kelt binding, når n er 0 som i bisesterne af oxalsyre, eller kan være enhver Cj-ø alkylen eller alkeny1engruppe, dvs. lige-Wherein preferably the R's are independently H or C 1-4 alkyl, preferably H, and n is a number from 0-6, preferably 2, the preferred anti-tartar agent being bis- (o-carboxy-phenyl) succinate ( BOCS). However, the group - (CRR) n - may be a narrow bond when n is 0 as in the bis ester of oxalic acid, or may be any C 1-6 alkylene or alkenylene group, ie. just-
DK 162419 BDK 162419 B
3 kædet eller forgrenet, mættet eller umættet afbrudt i kæden af 0 eller S, Cj-4 a 1koxysubsti tueret eller lignende. Når --CRR-gruppen er en del af en ethylenisk gruppe, kan den ene eller begge R være 0, dvs. erstattes med en valensbinding. Bis-(o-5 carboxyphenyl)-esterne af følgende alifatiske dicarboxylsyrer skal blot illustrere anti tandstensmi dl erne ifølge opfindelsen: oxalsyre (ethandisyre1 malonsyre (propandisyrel raysyre (butandisyrel 10 glutarsyre (pentandisyrel adipinsyre (hexandisyre) pimelinsyre (heptandisyrel korksyre (octandisyrel maleinsyre (1,2-ethylendicarboxylsyre HOOCCH ; CH-COOH) 15 itaconsyre (methylenravsyre HOOCC (JCE^) CH^COOH) isoravsyre (2-methylpropandisyre) rauconsyre (2,4-hexadiendisyre HOOCCH : CHCH : CH-COOH) dihydromuconsyre (HQOCC^C^CH : CHCOOH) 2o dihydroitaconsyre (methylravsyre) 3-ethylhexandisyre3 chained or branched, saturated or unsaturated interrupted in the chain of 0 or S, C 1-4 a 1 -koxy substituted or the like. When the --CRR group is part of an ethylenic group, one or both R may be 0, i.e. is replaced by a valence bond. The bis (o-5 carboxyphenyl) esters of the following aliphatic dicarboxylic acids are intended to illustrate only the anti-tartaric agents of the invention: oxalic acid (ethanedioic acid malonic acid (propanedioic acid) (butanedioic acid glutaric acid (pentanedioic acid) , 2-ethylenedicarboxylic acid HOOCCH; CH-COOH) itaconic acid (methylene succinic acid HOOCC (JCE ^) CH CH: CHCOOH) 2o dihydroitaconic acid (methyl succinic acid) 3-ethylhexanedioic acid
Endvidere kan den ene eller begge phenyldelene i dette middel være kernesubstitueret med en eller flere Gj-^alkyl eller al-25 koxygrupper, såsom methyl eller isobutoxy, eller halogen, så- sm chlor, brom, jod eller fluor.Furthermore, one or both of the phenyl moieties of this agent may be nucleosubstituted with one or more G 1 alkyl or alkoxy groups, such as methyl or isobutoxy, or halogen, such as chlorine, bromine, iodine or fluorine.
Egnede metoder til fremstilling af disse antitandstensmidler er beskrevet i førnævnte US patentskrift nr. 4.080.441. En an-30 den forbedret metode til denne fremstilling er beskrevet i ne denstående eksempel A.Suitable methods for preparing these anti-tartar agents are described in the aforementioned U.S. Patent No. 4,080,441. Another improved method of this preparation is described in the following Example A.
Det vil forstås, at den frie syreform af disse antitandstensmidler kan omdannes til og anvendes i deres ækvivalente salt-35 form ved behandling med en base indeholdende en oralt accep tabel kation, såsom alkalimetal (f.eks. natrium, kalium), jor-dalkalimetal (f.eks. calcium, magnium), metal, ammonium, mono-,It will be appreciated that the free acid form of these antitanking agents may be converted to and used in their equivalent salt form by treatment with a base containing an orally acceptable table cation such as alkali metal (e.g. sodium, potassium), alkaline earth metal (e.g., calcium, magnesium), metal, ammonium, mono-,
DK 162419 BDK 162419 B
4 di- eller tri-Ci_i8alkyl eller alkanolsubsti tueret ammonium eller organisk amin (f.eks. methyl-, ethyl-, hydroxy-ethylen-substituenter).4 di- or tri-C 1-8 alkyl or alkanol-substituted ammonium or organic amine (e.g., methyl, ethyl, hydroxyethylene substituents).
5 Antitandstensmidlerne i tandplejemidlet ifølge opfindelsen er antikernedannende midler, og er effektive til at reducere dannelse af tandsten uden unødig afkalkning af dental emaljen, og i modsætning til de ovennævnte kationiske, antibakterielle antiplakmidler og antitandstensmi dl er har disse midler ingen 10 eller ringe tendens til at misfarve tænderne og kan yderligere vise sig effektive til at reducere eller hæmme gingivitis.The dentifrice antifouling agents of the invention are anticorrosive agents, and are effective in reducing tartar formation without unnecessary descaling of the dental enamel, and, unlike the above cationic, antibacterial antifouling agents and antifouling agents, these agents have no or little tendency to discolor teeth and may further prove effective in reducing or inhibiting gingivitis.
Koncentrationen af disse antitandstensmidler i mundplejemidler kan variere meget, typisk opad fra ca. 0,01% efter vægt uden 15 nogen øvre grænse for mængden, der kan anvendes, undtagen for så vidt den er bestemt af omkostninger og uforenelighed med bæreren. I almindelighed anvendes koncentrationer fra ca. 0,01% til ca. 10%, fortrinsvis ca. 0,05% til ca. 8,0% og bedst ca. 0,1% til ca. 4 vægt%. Mundplejemidler, som under sædvanlig 20 brug kunne blive inrd-taget· ved en fejltagelse, indeholder for trinsvis koncentrationer i den nedre del af de førnævnte intervaller .The concentration of these antifungal agents in oral care products can vary greatly, typically upwards from approx. 0.01% by weight without an upper limit on the amount that can be used, except in so far as it is determined by cost and incompatibility with the carrier. Generally, concentrations from about 0.01% to approx. 10%, preferably approx. 0.05% to approx. 8.0% and best approx. 0.1% to approx. 4% by weight. Oral care products which could be mistakenly taken into use during normal use contain incremental concentrations in the lower portion of the aforementioned ranges.
Selv om disse antitandstensmidler varierer i vandopløselighed 25 afhængende af deres molekylvægt, identitet og mængder af salt dannende kationer, osv., er de tilstrækkeligt opløselige i vandige medier, f.eks. i mundhulen, i de lave koncentrationer anvendt heri til at kunne kaldes vandopløselige. Det har imidlertid uventet vist sig, at mundplejemidler indeholdende disse 30 midler i et vandigt medium undergår betydelig hydrolyse eller anden forringelse ved lagring. Ifølge opfindelsen angives der orale midler, som er i det væsentlige vandfrie, f.eks. indeholder 0 til mindre end ca. 0,2 mol vand pr. mol antitand-stensmiddel.Although these antitanking agents vary in water solubility 25 depending on their molecular weight, identity and amounts of salt forming cations, etc., they are sufficiently soluble in aqueous media, e.g. in the oral cavity, in the low concentrations used herein to be called water-soluble. However, it has unexpectedly been found that oral care agents containing these agents in an aqueous medium undergo considerable hydrolysis or other deterioration upon storage. According to the invention, oral agents which are substantially anhydrous, e.g. contains 0 to less than approx. 0.2 moles of water per mole of antitank stoning.
35 Når de orale midler ifølge opfindelsen er i væskeform, pastaform eller cremeform, såsom i mundvaskevæsker og skyl levæsker,When the oral agents of the invention are in liquid, paste or cream form, such as in mouthwashes and rinse fluids,
DK 162419 BDK 162419 B
5 tandpastaer og tandcremer, anvendes fortrinsvis en med vand blandbar (fortrinsvis vandopløselig) organisk normalt flydende, oralt acceptabel bærer. Typisk indbefatter disse bærere vandopløselige C2-4 monovalente og polyvalente alkaner og Cj_4 5 alkylethere deraf, såsom ethanol, ethylenglycol, methyl-, ethyl- og butylethere deraf (methyl-, ethyl- og butyl-Cello-solve®), propylenglycol, tetramethylenglycol og glycerin og vandopløselige poly/ethylenglycoler), såsom diethylenglycol, methyl-, ethyl-, diethyl- og butylethere deraf (methyl-, 10 ethyl-, diethyl- og butyl-Carbitol), triethylenglycol, lavmo- lekulære polyethylenglycoler, f.eks. 400, 600 og blandinger deraf, osv. Polyhydroxyforbi ndel ser i den førnævnte gruppe, især propylenglycol, glycerin og de lavmolekylære polyethylenglycoler, virker i almindelighed som fugtbindende midler, der 15 er ønskelige komponenter i mundplejemidlerne ifølge opfindel sen .For example, in toothpastes and toothpastes, a water-miscible (preferably water-soluble) organic normally liquid, orally acceptable carrier is used. Typically, these carriers include water-soluble C 2-4 monovalent and polyhydric alkanes and C 1-4 alkyl ethers thereof, such as ethanol, ethylene glycol, methyl, ethyl and butyl ethers thereof (methyl, ethyl and butyl-Cello-solv®), propylene glycol, tetramethylene glycol and glycerine and water-soluble polyethylene glycols) such as diethylene glycol, methyl, ethyl, diethyl and butyl ethers thereof (methyl, ethyl, diethyl and butyl Carbitol), triethylene glycol, low molecular weight polyethylene glycols, e.g. 400, 600 and mixtures thereof, etc. The polyhydroxy compound in the aforementioned group, especially propylene glycol, glycerine and the low molecular weight polyethylene glycols, generally acts as moisture binding agents which are desirable components of the oral care compositions of the invention.
Andre typer af disse med vand blandbare flydende bærere, der kan anvendes, er de polære, aprote opløsningsmidler, såsom di-20 methyl formamid og sulfoxid, N-methylpyrrolidon, sulfolan, te- tramethy1su1 fon, acetonitril og fortrinsvis ethylen og propy-1encarbonat.Other types of these water miscible liquid carriers which may be used are the polar aprotic solvents such as dimethyl formamide and sulfoxide, N-methylpyrrolidone, sulfolane, tetramethylsulfone, acetonitrile and preferably ethylene and propylene carbonate.
Organiske, flydende bærere, der er i det væsentlige ublandba-25 re med vand, kan også anvendes, og repræsentanter herfor er hydrocarbon, fedtsyre og fedtsyreesterolier, såsom mineralolie, tetradecan, pentan, capronsyre, ønantsyre, methylcaproat og laurat, ethylenglycoldicaprylat og lignende.Organic liquid carriers which are substantially miscible with water may also be used, and representatives thereof are hydrocarbon, fatty and fatty acid esters such as mineral oil, tetradecane, pentane, capric acid, oanoic acid, methylcaproate and laurate, ethylene glycol dicaprylate and the like.
30 Blandinger af samme typer og/eller forskellige typer flydende bærere som ovenfor beskrevet kan naturligvis anvendes.Of course, mixtures of the same types and / or different types of liquid carriers as described above can be used.
Mængden af den førnævnte flydende bærer, som anvendes i disse mundpi ejemi dl er, vil naturligvis afhænge for størstedelen af 35 den ønskede grad af flydenhed eller viskositet og kan let be stemmes rutinemæssigt i et givet tilfælde. Typisk indeholder flydende midler, såsom mundvaskevæsker og skyllevæsker ca. 70¾The amount of the aforementioned liquid carrier used in these mouthpieces will, of course, depend for most of the desired degree of fluidity or viscosity and can be readily determined routinely in a given case. Typically, liquid agents such as mouthwashes and rinse fluids contain approx. 70¾
DK 162419 BDK 162419 B
6 til ca. 99,9%, og tandpastaer og tandcremer indeholder ca. 10% til ca. 80 vægt% af en sådan flydende bærer, hvoraf ca. 10% til ca. 100% kan være et fugtbindende middel. Normalt faste fugtbindende midler, såsom sorbit kan også inkluderes.6 to approx. 99.9%, and toothpastes and toothpastes contain approx. 10% to approx. 80% by weight of such a liquid carrier, of which approx. 10% to approx. 100% can be a moisture-binding agent. Normally solid moisture binding agents such as sorbit may also be included.
55
Mundpiejemidlerne ifølge opfindelsen har typisk i vandigt medium, f.eks. i mundhulen, eller i form af en 20% vandig opslæmning eller opløsning en _pH-Vjaerdi på ca. 3,5 til ca. 8, fortrinsvis ca. 4 til ca. 7 og bedst ca. 4 til 6. Denne pH-10 værdi kan reguleres ved tilsætning af de nødvendige mængder sure stoffer, såsom citronsyre eller benzosyre, basiske stoffer, såsom natriumhydroxid-og/eller stødpudemidler, såsom natriumcitrat, benzoat, bicarbonat eller carbonat, dinatriumhy-drogenphosphat, natriumdihydrogenphosphat eller blandinger 15 deraf.The mouthwash agents of the invention typically have in aqueous medium, e.g. in the oral cavity, or in the form of a 20% aqueous slurry or solution, a pH value of approx. 3.5 to approx. 8, preferably approx. 4 to approx. 7 and best approx. This pH-10 value can be adjusted by adding the necessary amounts of acidic substances such as citric or benzoic acid, basic substances such as sodium hydroxide and / or buffers such as sodium citrate, benzoate, bicarbonate or carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate or mixtures thereof.
Bæreren i faste eller pastaagtige midler, såsom tandpulvere, tabletter, tandpastaer og tandcremer indeholder i reglen po-lermateriale. Eksempler på polermaterialer er vanduopløselige 20 natriummetaphopshat (IMP), ka1 iummetaphosphat, tricalciumphos- phat, vandfrit monohydrat i seret og dihydratiseret calcium og dicalciumphosphat, calciumpyrophosphat, magniumorthophosphat, trimagn.iumphosphat, magnium- og calciumcar.bonat og. sulfat, aluminiumoxid, hydratiseret aluminiumoxid, aluminiumsilikat, 25 alkalimetal og jordalkalimetalaluminiumsilikater, zirkonsili kat, si 1iciumdioxid, bentonit og blandinger deraf. Foretrukne polermaterialer indbefatter krystallinsk og kolloid silicium-dioxid, silicagel, komplekst, amorft alkalimetalaluminiumsi-likat, hydratiseret aluminiumoxid og IMP.The carrier in solid or paste-like agents, such as tooth powders, tablets, toothpastes and toothpastes, usually contains powder material. Examples of polishing materials are water-insoluble sodium metaphhopate (IMP), calcium metaphosphate, tricalcium phosphate, anhydrous monohydrate in serous and dihydrated calcium and dicalcium phosphate, calcium pyrophosphate, magnesium orthophosphate, trimagnium and calcium phosphate, magnesium and calcium. sulphate, alumina, hydrated alumina, aluminosilicate, alkali metal and alkaline earth metal aluminosilicates, zirconium silicate, silica, bentonite and mixtures thereof. Preferred polishes include crystalline and colloidal silica, silica gel, complex, amorphous alkali metal aluminum silicate, hydrated alumina and IMP.
3030
Aluminiumoxid, især det hydrat i serede aluminiumoxid, der forhandles af Alcoa som C333, der har et aluminiumoxidindhold på 64,9 vægt%, et siliciumdioxidindhold på 0,008%, et ferrioxid-indhold på 0,003% og et fugtighedsindhold på 0,37% ved 110°C, 35 og som har en vægtfylde på 2,42 og en sådan partikelstørrelse, at 100% af partiklerne er mindre end 50 mikron, og 84% af partiklerne er mindre end 20 mikron, er meget effektivt.Alumina, in particular the hydrated alumina hydrate marketed by Alcoa as C333, having an alumina content of 64.9% by weight, a silica content of 0.008%, a ferric oxide content of 0.003% and a moisture content of 0.37% at 110 ° C, 35 and having a density of 2.42 and a particle size such that 100% of the particles are less than 50 microns and 84% of the particles are less than 20 microns, is very effective.
DK 162419 BDK 162419 B
7 Når der anvendes visuelt klare geler, er et polermiddel af kolloidt si 1iciumdioxid, såsom de der forhandles under varemærket SYLOID® som Syloid 72 74 eller 244 eller under varemærket SANTOCEL™ (ej reg.) som Santocel 100, og alkalimetalalu-5 miniumsi1ikatkomplekser særligt nyttige, da de har brydnings- indeks tæt ved brydningsindekset af de systemer af geleringsmiddel og væske, der almindeligvis anvendes i tandplejemidler.7 When visually clear gels are used, a colloidal silicon dioxide polish such as those sold under the trademark SYLOID® as Syloid 72 74 or 244 or under the trademark SANTOCEL ™ (not reg.) As Santocel 100, and alkali metal aluminum silicate complexes are particularly useful since they have refractive index close to the refractive index of the gelling and liquid systems commonly used in dentifrices.
Mange af de såkaldte vanduopløselige polermaterialer er af an-10 ionisk karakter og indeholder også små mængder opløseligt ma teriale. Uopløseligt natriummetaphosphat kan således være dannet på enhver egnet måde som illustreret af Thorpes Dictionary of Applied Chemistry, bind 9, 4. udgave, side 510-511. De former af uopløseligt natrimmetaphosphat, der er kendt som Ma-15 drell's salt og Kurrol's salt er andre eksempler på egnede ma terialer. Disse metaphosphater udviser en ganske lille opløselighed i vand og omtales derfor i almindelighed som uopløselige metaphosphater. Der findes deri en mindre mængde opløseligt phosphatmateriale som urenheder, i reglen nogle få procent, 20 såsom op til 4 vægt%. Mængden af opløseligt phosphatmateriale, der antages at indbefatte et opløseligt natriumtrimetaphos-phat, hvis det drejer sig om uopløseligt metaphosphat, kan reduceres ved vask med vand, hvis det ønskes. Det opløselige alkal imeta1metaphosphat anvendes typisk i pulverform med en så-25 dan partikelstørrelse, at ikke mere end 1% af materialet er større end ca. 37 mikron.Many of the so-called water-insoluble polishing materials are of anionic nature and also contain small amounts of soluble material. Thus, insoluble sodium metaphosphate may be formed in any suitable manner as illustrated by Thorpes Dictionary of Applied Chemistry, Volume 9, 4th Edition, pages 510-511. The forms of insoluble sodium trimetaphosphate known as the salt of Ma- drell and Kurrol's salt are other examples of suitable materials. These metaphosphates exhibit very little solubility in water and are therefore generally referred to as insoluble metaphosphates. There is a smaller amount of soluble phosphate material as impurities, usually a few percent, such as up to 4% by weight. The amount of soluble phosphate material which is believed to include a soluble sodium trimetaphosphate in the case of insoluble metaphosphate can be reduced by washing with water if desired. The soluble alkaline imetimethaphosphate is typically used in powder form with a particle size such that no more than 1% of the material is greater than about 10%. 37 microns.
Polermaterialet findes i almindelighed i mængder, der ligger fra ca. 20% til ca. 99 vægt% af mundplejemidlet. Fortrinsvis 30 findes det i mængder, der ligger fra 20% til ca. 75% i tandpasta og fra ca. 70% til ca. 99% i tandpulver.The polishing material is generally found in amounts ranging from approx. 20% to approx. 99% by weight of the oral care product. Preferably, it is found in amounts ranging from about 20% to about 75% in toothpaste and from approx. 70% to approx. 99% in tooth powder.
Ved fremstilling af tandpulvere er det i reglen tilstrækkeligt mekan i sk at blande, f.eks. ved formaling, de forskellige faste 35 bestanddele i passende mængder og partikelstørrelser.In the manufacture of dental powders, it is usually sufficient mechanical to mix, e.g. by grinding, the various solid components in appropriate amounts and particle sizes.
I en tandpastacreme eller gel afpasses mængderne af væsker og faste stoffer typisk til dannelse af en cremeagtig eller gele- 8In a toothpaste cream or gel, the amounts of liquids and solids are typically adjusted to form a creamy or gel-like.
DK 16 2 419 BDK 16 2 419 B
ret masse, som kan udpresses fra en trykbeholder eller af en sammentrykkelig tube. Fortykkelse til den rigtige ønskede viskositet eller strømmeevne lettes typisk eller opnås ved at inkludere et bindemiddel, fortykkelsesmiddel eller gelerings-5 middel, såsom naturlige eller syntetiske gummier eller gummi- agtige materialer, typisk irsk mos, Pluronic®, natriumcarboxy-methylcellulose og carboxyethylcellulose, methylcellulose, hy-droxyethylcellulose, hydroxypropyl cellulose, hydroxypropy1me-thylcellulose, hydroxybutylmethylcellulose, Laponite® CP eller 10 SP (syntetisk hectoritler fra Laporte Industries Ltd.), visca-rin, gelatine, glucose, saccharose, Carbopol® (f.eks. 934, 940 og 941), karayagummi. gummiarabicum, -t rag-an t, polyvinyl-pyrrolidon, polyvinylalkohol og stivelse. De findes i reglen enkeltvis eller flere sammen i en mængde op til ca. 10 vægt%, 15 fortrinsvis i intervallet fra ca. 0,5% til ca. 5%. De fore trukne geleringsmidler er PLURONICer og hydroxypropylcellulo-se. PLURONICer, såsom F108 og F127 er polyoxypropylenpolyoxy-ethy1en-blokpolymerer, der samtidigt virker som ikke-ioniske overfladeaktive midler.fairly mass, which can be squeezed from a pressure vessel or by a compressible tube. Thickening to the desired viscosity or flowability is typically facilitated or achieved by including a binder, thickener or gelling agent such as natural or synthetic gums or gum materials, typically Irish moss, Pluronic®, sodium carboxymethyl cellulose and carboxyethyl cellulose, methyl cellulose , hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, hydroxybutyl methyl cellulose, Laponite® CP or 10 SP (synthetic hectoritles from Laporte Industries Ltd.), viscarin, gelatin, glucose, sucrose, Carbopol® (eg 934, 9 and 941), karaya rubber. gum arabic, rag-an t, polyvinylpyrrolidone, polyvinyl alcohol and starch. They are usually found individually or several together in an amount up to approx. 10 weight percent, preferably in the range of about 0.5% to approx. 5%. The preferred gelling agents are PLURONICs and hydroxypropyl cellulose. PLURONICs such as F108 and F127 are polyoxypropylene polyoxyethylene block polymers which simultaneously act as nonionic surfactants.
2020
Mundplejemidlerne ifølge opfindelsen kan indeholde et ikke-sæ-beagtigt syntetisk tilstrækkeligt vandopløseligt, organisk, anionisk eller ikke-ionisk overfladeaktivt middel i koncentrationer, der i almindelighed ligger fra ca. 0,05 til ca. 10, 25 fortrinsvis ca. 0,5 til ca. 5 vægt%, for at fremme befugtning og rensende og skummende egenskaber. Vedrørende egnede anio-niske overfladeaktive midler og egnede ikke-ioniske overfladeaktive midler henvises til US patentskrift nr. 4.041.149.The oral care compositions of the invention may contain a non-sealable synthetic sufficiently water-soluble, organic, anionic or nonionic surfactant at concentrations generally ranging from about 1 to about 5%. 0.05 to approx. 10, 25 preferably approx. 0.5 to approx. 5% by weight, to promote wetting and cleansing and foaming properties. For suitable anionic surfactants and suitable nonionic surfactants, see U.S. Patent No. 4,041,149.
30 I visse udførelsesformer ifølge opfindelsen er en fluorgiven de forbindelse til stede i mundplejemidlet. Disse forbindelser kan være svagt opløselige i vand eller være helt vandopløselige. De er karakteristiske ved deres evne til at frigøre fluorioner i vand og ved i det væsentlige at være fri for reaktion 35 med andre forbindelser i mundplejemidlet. Blandt disse materi aler er uorganiske fluorider, såsom opløselige alkalimetal-, jordalkali metal - og tungmetalsalte, f.eks. natriumfluorid, ka-In certain embodiments of the invention, a fluorine-given compound is present in the oral care agent. These compounds may be slightly water-soluble or completely water-soluble. They are characterized by their ability to release fluorine ions in water and by being essentially free of reaction 35 with other compounds in the oral care agent. Among these materials are inorganic fluorides such as soluble alkali metal, alkaline earth metal and heavy metal salts, e.g. sodium fluoride,
DK 162419 BDK 162419 B
9 1 iumf luorid, ammoniumfluorid, calciumf luorid, et kobberfluorid, såsom cuprofluorid, zinkfluorid, et tinfluorid, såsom stanrrifluorid eller stannochlorfluorid, bariumfluorid, natriumf luorsilikat, ammoniumfluorsi1ikat, natriumfluorzirkonat, 5 natriummonof1uorphosphat, aluminiummono- og difluorphosphat og fluoreret natriumcalciumpyrophosphat. Alkalimetal- og tinfluorider, såsom natrium- og stannofluorid, natriummonofluorphosphat og blandinger deraf, foretrækkes.9 to 9 fluoride, ammonium fluoride, calcium fluoride, a copper fluoride, such as copper fluoride, zinc fluoride, a tin fluoride, such as stannous trifluoride or stannous chlorofluoride, barium fluoride, sodium fluoride, sodium sulfate, ammonium fluoride, Alkali metal and tin fluorides such as sodium and stannofluoride, sodium monofluorophosphate and mixtures thereof are preferred.
10 Mængden af den fluorgivende forbindelse afhænger til en vis grad af typen af forbindelse, dens opløselighed og typen af mundplejemiddel, men skal være en ugiftig mængde. I et fortykket eller fast mundplejemiddel, såsom tandpasta eller tandpulver, anses en mængde af en sådan forbindelse, der frigør mak-15 simalt ca. 1 vægt% af præparatet, for tilfredsstillende. En hver egnet minimal mængde af en sådan forbindelse kan anvendes, men det foretrækkes at anvende tilstrækkelig meget forbindelse til at frigøre ca. 0,005% til 1% og fortrinsvis ca. 0,1% fluoridion. Typisk, hvor det drejer sig om alkalimetal-20 fluorider og stannofluorid, findes denne komponent i op til ca. 2 vægt% beregnt på vægten af præparatet og fortrinsvis i intervallet fra ca. 0,05 til 1%. Hvis det drejer sig om natriummonof 1 uorphosphat , kan forbindelsen findes i en mængde op til 7,6 vægt%, mere typisk ca. 0,5 til ca. 1 vægt%.The amount of the fluorine-providing compound depends to some extent on the type of compound, its solubility and the type of oral care agent, but must be a non-toxic amount. In a thickened or solid oral care agent, such as toothpaste or tooth powder, an amount of such a compound which releases a maximum of approx. 1% by weight of the preparation, too satisfactory. Any suitable minimal amount of such a compound may be used, but it is preferred to use sufficient compound to release approx. 0.005% to 1% and preferably approx. 0.1% fluoride ion. Typically, in the case of alkali metal fluorides and stannofluoride, this component is found in up to about 10%. 2% by weight based on the weight of the composition and preferably in the range of about 0.05 to 1%. In the case of sodium monofilorphosphate, the compound can be found in an amount up to 7.6% by weight, more typically approx. 0.5 to approx. 1% by weight.
25 I et flydende mundplejemiddel, såsom en mundvaskevæske, findes den fluorgivende forbindelse typisk i en mængde, der er tilstrækkelig til at frigøre op til ca. 0,005 til ca. 0,2%, fortrinsvis ca. 0,001 til ca. 0,1% og bedst ca. 0,0013 vægt% flu-30 oridion.In a liquid oral care agent, such as a mouthwash liquid, the fluorine-providing compound is typically present in an amount sufficient to release up to approx. 0.005 to approx. 0.2%, preferably approx. 0.001 to approx. 0.1% and best approx. 0.0013 wt% fluoride ion.
Forskellige andre materialer kan inkorporeres i mundpiejemid-lerne ifølge opfindelsen, såsom hvidgørende midler, konserveringsmidler, siliconer, chlorophylforbi ndel ser, andre anti-35 tandstensmidler, antibakterielle antiplakmidler og/eller ammo- nierede materialer, såsom urinstof, diammoniumphosphat og blandinger deraf. Når disse tilsætninger er til stede, inkorVarious other materials can be incorporated into the mouth care agents of the invention, such as whitening agents, preservatives, silicones, chlorophyll compounds, other anti-tartar agents, antibacterial anti-plaque agents and / or ammoniated materials such as urea, diammonium phosphate and mixtures thereof. When these additions are present, incorporate
. DK 162419 B. DK 162419 B
10 poreres de i præparaterne i mængder, som ikke har nogen væsentlig skadelig virkning på de ønskede egenskaber.10, they are porated in the compositions in amounts which have no significant detrimental effect on the desired properties.
Ethvert egnet aromatiserende eller sødende materiale kan også 5 anvendes.Any suitable flavoring or sweetening material may also be used.
Eksempler på egnede aromatiserende bestanddele er aromatise rende olier, f.eks. olier af havemynte, pebermynte, vintergrøn, sassafras, kryddernen ike, salvie, eucalyptus, merian, 10 kanel, citron og appelsin, mentol, eugenol, cineol og methyl-salicylat. Egnede sødemidler indbefatter saccharose, fructose, lactose, maltose, sorbit, xylit, natriumcyclamat perillartin, APM (aspartylphenylalaninmethylester) og saccharin. Hensigtsmæssigt kan aroma og sødemiddel tilsammen udgøre fra ca. 0,01 15 til 5% eller mere af præparatet.Examples of suitable aromatizing ingredients are aromatic oils, e.g. garden mint, peppermint, winter green, sassafras, spice ike, sage, eucalyptus, marjoram, 10 cinnamon, lemon and orange, menthol, eugenol, cineol and methyl salicylate. Suitable sweeteners include sucrose, fructose, lactose, maltose, sorbit, xylite, sodium cyclamate perillartin, APM (aspartylphenylalanine methyl ester) and saccharin. Conveniently, the aroma and sweetener may together amount to approx. 0.01 to 5% or more of the composition.
Ved fremstilling af mundplejemidlerne ifølge opfindelsen foretrækkes det, men er ikke væsentligt, at tilsætte antitand-stensmidlet, efter at de andre bestanddele er blandet og bragt 20 i kontakt med hinanden for at undgå en tendens til, at dette middel udfældes.In the preparation of the oral care compositions of the invention, it is preferred, but not essential, to add the antitanking agent after the other ingredients are mixed and brought into contact with each other to avoid a tendency for this agent to precipitate.
Det vil forstås, at mundplejemidlerne på sædvanlig måde skal sælges eller på anden måde fordeles i passende mærkede paknin-25 ger. Et glas med mundsky 11 evæske vil således have en etiket, der beskriver det som en mundsky 1 levæske eller mundvaskevæske, og som indeholder brugsanvisning, og en tandpasta vil i reglen være i en sammentrykkelig tube, typisk aluminium, foret bly eller plast, eller en anden sammentrykkelig pakning til 30 udmåling af indholdet, som har en etiket, der beskriver det som en tandpaste eller tandcreme.It will be understood that the oral care products must be sold in the usual manner or otherwise distributed in suitably labeled packages. Thus, a glass with a mouthwash 11 liquid will have a label describing it as a mouthwash 1 liquid or mouthwash liquid and containing instructions for use, and a toothpaste will usually be in a compressible tube, typically aluminum, lined lead or plastic, or a another compressible pack for measuring the contents having a label describing it as a toothpaste or toothpaste.
Ved udførelse af opfindelsen bliver et mundpiejemiddel ifølge opfindelsen, såsom en mundvaskevæske eller tandpasta, indehol-35 dende det beskrevne antitandstensmiddel i en mængde effektiv til at hindre tandsten på tandoverflader, anvendt regelmæssigt i mundhulen, især på tandemaljen, fortrinsvis fra 1-3 gange daglig.In carrying out the invention, a mouthwash agent according to the invention, such as a mouthwash liquid or toothpaste, containing the described anti-toothpaste agent in an amount effective to prevent tartar on tooth surfaces is used regularly in the oral cavity, especially on the tooth enamel, preferably from 1-3 times daily. .
1111
DK 162419 BDK 162419 B
Eksempel AExample A
Fremstilling af bis(o-carboxyphenyl)succinat 0,4 mol salicylsyre (55,2 g) 5 0,4 mol pyridin (31,2 mil 0,2 mol succinylchlorid (31,0 gi.Preparation of bis (o-carboxyphenyl) succinate 0.4 mol of salicylic acid (55.2 g) 0.4 mol of pyridine (31.2 mil 0.2 mol of succinyl chloride (31.0 g).
Salicylsyren og pyridinen opløses i 90 ml acetone. Til den 10 fremkomne klare opløsning sættes succinylchloridet i 90 ml acetone under omrøring med en hastighed, der holder acetonen under tilbagesvaling i \ time. Under denne tilsætning begynder det ønskede BOCS-produkt at udskille sig, og blandingen bliver mørk purpurfarvet. Reaktionsopslæmningen omrøres i % time, ef-15 ter at alt succinylchloridet er blevet tilsat. Derefter tilsættes 200 ml vand, acetonen afdampes fra opslæmningen på roterende fordamper ved 35°C, og det ønskede BOCS-produkt opsamles på et sugefilter, vaskes med vand og tørres i vakuum ved 60°C.The salicylic acid and pyridine are dissolved in 90 ml of acetone. To the resulting clear solution, the succinyl chloride is added to 90 ml of acetone with stirring at a rate which keeps the acetone under reflux for 1 hour. During this addition, the desired BOCS product begins to separate and the mixture turns dark purple. The reaction slurry is stirred for 1 hour after all the succinyl chloride has been added. Then 200 ml of water is added, the acetone is evaporated from the slurry on a rotary evaporator at 35 ° C and the desired BOCS product is collected on a suction filter, washed with water and dried in vacuo at 60 ° C.
2020
Udbytte 66,5 g (93%)Yield 66.5 g (93%)
Smp. 177-177,5°CMp. 177 to 177.5 ° C
Neutral iser i ngsækvivalent 179,9*Neutral Ices in Equivalent 179.9 *
Forsæbningsækvivalent 186,8* 25 * Beregnet for CjgH^Og.Saponification equivalent 186.8 * 25 * Calculated for C
De følgende eksempler illustrerer nærmere karakteren af den foreliggende opfindelse. Alle mængder omtalt i det følgende er efter vægt og temperaturer i °C, med mindre andet er anført.The following examples further illustrate the nature of the present invention. All amounts discussed below are by weight and temperatures in ° C, unless otherwise stated.
3030
Eksempel 1 Følgende sammensætning illustrerer en tandpasta ifølge opfindelsen, der er effektiv til at hindre tandsten.Example 1 The following composition illustrates a toothpaste according to the invention that is effective in preventing tartar.
35 535 5
. DK 162419 B. DK 162419 B
12 Vægtdele12 Weight Parts
Propylenglycol 42,0Propylene glycol 42.0
Hydroxypropylcellulose 1,0Hydroxypropyl cellulose 1.0
Polyethylenglycol 60Q 10,0Polyethylene Glycol 60Q 10.0
Natriumsaccharin 0,2Sodium saccharin 0.2
Ti02 0,4 IMP 28,0TiO2 0.4 IMP 28.0
Syloid 244 12,0Syloid 244 12.0
Natriumlaurylsulfat 1,5Sodium lauryl sulfate 1.5
Aroma 1,o ' BOCS 3,0Aroma 1, o 'BOCS 3.0
De følgende sammensætninger, der er anført i vægtdele, illu-15 strerer mundvaskevæsker ifølge opfindelsen som er effektive til at hindre tandsten.The following compositions listed in parts by weight illustrate mouthwash fluids of the invention which are effective in preventing tartar.
' Eksempel 2..... 3' ' 4 20 Aroma, 0,22 0,22 0,22Example 2 ..... 3 4 Flavor, 0.22 0.22 0.22
Ethanol 15,0 15,0 15,0Ethanol 15.0 15.0 15.0
Pluronic F108 3,0 3,0 3,0Pluronic F108 3.0 3.0 3.0
Glycerin 1Q,0 10,0 10,0Glycerin 1Q, 0 10.0 10.0
Natriumsaccharin Q,03 0,03 0,03 25 BOCS °rQ5 °'50 1'°Sodium saccharin Q, 0.03 0.03 0.03 25 BOCS ° rQ5 ° '50 1' °
Mundvaskevæskerne i eksempel 2-4 ovenfor kan anvendes i mundhulen, som de er eller efter fortynding med ca. 2-4 gange deres rumfang vand, dvs. rumfangsforhold mellem præparat og vand 30 på ca. 1:2 til ca. 1:4.The mouthwashes of Examples 2-4 above can be used in the oral cavity as they are or after dilution by ca. 2-4 times their volume of water, ie. volume ratio of preparation to water 30 of approx. 1: 2 to approx. 1: 4.
Anvendelse af ækvivalente mængder af følgende bisesterholdige forbindelser i stedet for BOCS anvendt i præparaterne i eksempel 2-5 giver præparater, der også er effektive til at hindre 35 tandsten.Use of equivalent amounts of the following bisester-containing compounds instead of BOCS used in the compositions of Examples 2-5 gives compositions which are also effective in preventing tartar.
1313
DK 162419 BDK 162419 B
Eksempel Bis-esterholdig forbindelse 5 bis(2-carboxy-4-butoxyphenyl)oxalat 6 bis(2-carboxyl-4-propyl-6-chlorphenyl)glutarat 7 bis(2-carboxy-4-methyl-6-bromphenyl)adipat 5 8 bis(2-carboxy-4-jod-6-ethoxyphenyl)suberat 9 bis (2-^carboxyphenyll pimelat 10 bis(2-carboxy-5-methoxyphenyl)malonat 11 bis (2i-carboxy-6-butylphenyl)maleat 12 bis(2-carboxyphenyllitaconat 10 13 bis (2 -c ar boxy-4 - f luor phenyl) muconatExample Bis-ester-containing compound 5 bis (2-carboxy-4-butoxyphenyl) oxalate 6 bis (2-carboxyl-4-propyl-6-chlorophenyl) glutarate 7 bis (2-carboxy-4-methyl-6-bromophenyl) adipate 5 8 bis (2-carboxy-4-iodo-6-ethoxyphenyl) suberated 9 bis (2- carboxyphenyl pimelate 10 bis (2-carboxy-5-methoxyphenyl) malonate 11 bis (2i-carboxy-6-butylphenyl) maleate 12 bis (2-carboxyphenyl lithaconate 13 bis (2-carboxy-4-fluorophenyl) muconate
Eksempel 14Example 14
Ved denne undersøgelse på 24 rotter blev en placebo af vand og 15 en 0,1¾ opløsning af BOCS i di methylsu1foxi d, pH 7,10, som eksperimentel antitandstensmundskyl levæske bedømt for effektivitet overfor dannelse af tandsten i en periode på 30 dage.In this study in 24 rats, a placebo of water and 15 a 0.1¾ solution of BOCS in di methylsulfoxy d, pH 7.10, was evaluated as experimental antitumor rinse fluid for efficacy against tartar formation for a period of 30 days.
Der anvendes Osborne-Mendel-rotter, som er vokset op i kuld.Osborne-Mendel rats used in litters are used.
På dage 21 og 22 podes de intraoralt med Strepmutans og Acti-20 nomyces viscsous og fæces fra cariesaktive Osborne-Mendel-rot ter, der var sat på kalkulogenkost 580F suppleret med 0,2% P som Na2P04. Placeboen og forsøgsmundskyllevæsken blev hver påført på kindtænder i en gruppe på 12 sådanne rotter to gange daglig mandag til fredag og en gang daglig lørdag og søndag i 2 5 en per i ode på 30 dage. Dyrene vejes ved begyndelsen og afslut ningen af undersøgelsen for at sikre, at rotterne forbliver i en i øvrigt normal tilstand. Efter endt periode bedømmes tandstensdannelsen ved rutinemetoder, og der findes følgende resultater: 3 0 35On days 21 and 22, they were grafted intraorally with Strepmutans and Acti-nomyces viscous and faeces from caries-active Osborne-Mendel rats, which were placed on calculus diet 580F supplemented with 0.2% P as Na 2 PO 4. The placebo and test mouthwash were each applied to cheek teeth in a group of 12 such rats twice daily Monday through Friday and once daily Saturday and Sunday for 25 days per 30 day ode. The animals are weighed at the beginning and end of the study to ensure that the rats remain in an otherwise normal state. At the end of the period, tartar formation is assessed by routine methods and the following results are found: 3 0 35
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31780381A | 1981-11-03 | 1981-11-03 | |
US31780381 | 1981-11-03 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK480582A DK480582A (en) | 1983-05-04 |
DK162419B true DK162419B (en) | 1991-10-28 |
DK162419C DK162419C (en) | 1992-03-23 |
Family
ID=23235335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK480582A DK162419C (en) | 1981-11-03 | 1982-10-29 | ORAL COSMETICS THAT EFFECTS THE TURTLE |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS58109408A (en) |
AU (1) | AU558985B2 (en) |
BE (1) | BE894898A (en) |
BR (1) | BR8206314A (en) |
CA (1) | CA1198680A (en) |
CH (1) | CH652023A5 (en) |
DE (1) | DE3239976A1 (en) |
DK (1) | DK162419C (en) |
FR (1) | FR2515512B1 (en) |
GB (1) | GB2109686B (en) |
IT (1) | IT1149112B (en) |
MX (1) | MX159074A (en) |
NZ (1) | NZ202301A (en) |
PH (1) | PH24866A (en) |
SE (1) | SE453359B (en) |
ZA (1) | ZA827793B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5094870A (en) * | 1989-05-30 | 1992-03-10 | Nabisco Brands, Inc. | Canine biscuits containing an inorganic pyrophosphate |
JP2905144B2 (en) * | 1995-09-14 | 1999-06-14 | 有限会社野々川商事 | Stick cosmetic container |
ES2369849T3 (en) * | 2002-11-07 | 2011-12-07 | Taisho Pharmaceutical Co., Ltd | BASE FOR ORAL COMPOSITION AND ORAL COMPOSITION. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4080441A (en) * | 1976-12-27 | 1978-03-21 | Colgate-Palmolive Company | Antibacterial oral composition |
US4289753A (en) * | 1977-04-04 | 1981-09-15 | Monsanto Company | Calculus-inhibiting method and compositions |
-
1982
- 1982-10-09 MX MX195013A patent/MX159074A/en unknown
- 1982-10-25 ZA ZA827793A patent/ZA827793B/en unknown
- 1982-10-27 NZ NZ202301A patent/NZ202301A/en unknown
- 1982-10-28 DE DE19823239976 patent/DE3239976A1/en not_active Withdrawn
- 1982-10-29 DK DK480582A patent/DK162419C/en not_active IP Right Cessation
- 1982-10-29 BR BR8206314A patent/BR8206314A/en unknown
- 1982-10-29 PH PH28064A patent/PH24866A/en unknown
- 1982-11-02 CA CA000414652A patent/CA1198680A/en not_active Expired
- 1982-11-02 JP JP57193246A patent/JPS58109408A/en active Granted
- 1982-11-02 FR FR8218341A patent/FR2515512B1/en not_active Expired
- 1982-11-02 SE SE8206226A patent/SE453359B/en not_active IP Right Cessation
- 1982-11-03 BE BE0/209387A patent/BE894898A/en not_active IP Right Cessation
- 1982-11-03 GB GB08231429A patent/GB2109686B/en not_active Expired
- 1982-11-03 CH CH6389/82A patent/CH652023A5/en not_active IP Right Cessation
- 1982-11-03 IT IT49413/82A patent/IT1149112B/en active
- 1982-11-03 AU AU90119/82A patent/AU558985B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
FR2515512B1 (en) | 1987-06-12 |
GB2109686B (en) | 1985-04-11 |
MX159074A (en) | 1989-04-14 |
IT8249413A0 (en) | 1982-11-03 |
DE3239976A1 (en) | 1983-05-11 |
IT1149112B (en) | 1986-12-03 |
AU558985B2 (en) | 1987-02-19 |
DK162419C (en) | 1992-03-23 |
SE453359B (en) | 1988-02-01 |
PH24866A (en) | 1990-12-26 |
NZ202301A (en) | 1985-02-28 |
CH652023A5 (en) | 1985-10-31 |
CA1198680A (en) | 1985-12-31 |
BR8206314A (en) | 1983-09-20 |
JPS58109408A (en) | 1983-06-29 |
SE8206226D0 (en) | 1982-11-02 |
BE894898A (en) | 1983-05-03 |
FR2515512A1 (en) | 1983-05-06 |
JPH0247963B2 (en) | 1990-10-23 |
SE8206226L (en) | 1983-05-04 |
DK480582A (en) | 1983-05-04 |
GB2109686A (en) | 1983-06-08 |
ZA827793B (en) | 1984-06-27 |
AU9011982A (en) | 1983-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI440473B (en) | Low water stannous fluoride plus zinc citrate dentifrice with improved stability, rheology, and efficacy | |
US4273759A (en) | Antibacterial oral composition | |
RU2162319C1 (en) | Compositions for teeth cleaning containing polyphosphate and fluoride | |
CA2235470C (en) | Dentifrice compositions containing .beta.-phase calcium pyrophosphate, an anticalculus agent, and fluoride | |
NL7904545A (en) | ORAL TREATMENT MIXTURE AND METHOD FOR PREVENTING AND CONTROLLING DENTAL STONE. | |
US4224309A (en) | Antibacterial oral composition | |
JPS6216924B2 (en) | ||
JPH06506466A (en) | Quaternary ammonium antibacterial toothpaste with selected calcium abrasives | |
JPS6332763B2 (en) | ||
DK165936B (en) | CLEANING OR MENTAL CLEANING CONTAINING A NON-IONIC SURFACTIVE POLY (HYDROXYPROPYLETHER) | |
US4118476A (en) | Antibacterial oral composition | |
JPS644487B2 (en) | ||
JPH0239482B2 (en) | ||
US4474750A (en) | Anticalculus oral composition | |
JPH02323B2 (en) | ||
US4118473A (en) | Antibacterial oral composition | |
KR880001750B1 (en) | Anticalculus oral composition | |
DK156618B (en) | ANTIBACTERIAL ORAL AGENT | |
DK162419B (en) | ORAL COSMETICS THAT EFFECTS THE TURTLE | |
PT92302A (en) | Process for the preparation of an oral anti-bacterial composition comprising an anti-bacterial agent and an aminoguanidine | |
US4175120A (en) | Dentifrice | |
US4105758A (en) | Oral compositions containing an anticalculus agent | |
USRE30675E (en) | Dentifrice | |
CA1087098A (en) | Oral composition of antibacterial antiplaque agent with polyamine polyphosphonic compound | |
NL8004619A (en) | MOUTH TREATMENT MIX AND METHOD FOR IMPROVING THE MOUTH HYGIENE. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |